Clinical trial
Vitamin D Supplementation to Persistent Carriers of MRSA - A Double Blind, Randomised Controlled Trial
NCT02178488 is registered in ClinicalTrials.gov with Peter Bergman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vitamin D Supplementation to Persistent Carriers of MRSA - A Double Blind, Randomised Controlled Trial
- Lead sponsor
- Peter Bergman
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- December 31, 2017
- Enrollment
- 60 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
methicillin resistant staphylococcus aureus, vitamin d3 deficiency